November 7-8, 2018 | Baltimore, MD
At CBI’s 10th Federal Pricing and Reporting Summit, elevate the conversation and take a deep dive into the complexity of contracting with the “Big 4” federal programs. In an era of political transformation and industry uncertainty, this highly acclaimed meeting is a must-attend, offering bio/pharma manufacturers best practices and timely updates from government officials and industry counterparts on pricing models and processes for complying with complicated rules and regulations.
With perspectives from Marci Anderson of the VA, Vincent Valinotti of the DoD, Captain Robert W. Hayes of PHS, and Captain Mike Crockett of the BoP, along with a Spotlight Session from J'Aime Conrod and Eric Escobar of UCB, this is a meeting you can't afford to miss!
Visit www.cbinet.com/fedpricing for further details and to register. Drug Channels readers will save $300 off the standard rate when they use discount code ATT954 and register prior to October 12th.*
You can read all about the Summit here.
Featured Sessions Include:
- Uncover leading strategies and best practices for coordination with the DoD
- Receive answers to critical questions related to TAA Non-Compliant Covered Drugs Policy and its specific role in the Acetris Health LLC v. United States court cases
- Navigate the recent and impending changes to 340B legislation and guidance and their impact on federal contracting and reporting
- Discuss the financial implications of government contracting strategies in the context of GTN
- Analyze and build your understanding of non-FAMP and Federal Ceiling Price with regard to the calculations and data from which they are derived
- Gain insight on key challenges surrounding the Federal Supply Schedule (FSS)
- Hear directly from the VA OIG regarding FSS contract compliance and audit expectations
CBI will see you there!
*Cannot be combined with other offers or used towards a current registration. Cannot be combined with special category rate or non-profit rates. Other restrictions may apply.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.